Curr Pain Headache Rep. 2005 Feb;9(1):65-70.

Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.

Source

Chelsea Community Hospital, Department of Pharmaceutical Care Services, 775 South Main Street, Chelsea, MI 48118, USA. sswidan@umich.edu

Abstract

This study was conducted to compare the efficacy of intravenous diphenhydramine with dihydroergotamine mesylate (DHE-45; Novartis International AG, Switzerland) in the treatment of severe, refractory, migraine headache. A retrospective review was conducted to include eighty randomly chosen patients who were admitted to the Michigan Head Pain & Neurological Institute's inpatient program at Chelsea Community Hospital. Patients had received nine doses of diphenhydramine or nine doses of DHE-45 during a 3-day period. Patients receiving DHE-45 also received metoclopramide (Reglan; AH Robins Company, Inc., Richmond, VA) as prophylaxis for nausea. Demographics, headache diagnosis, psychiatric discharge diagnoses, abortive medications, and adverse events were recorded and assessed.

PMID:: 15625028; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Comparative Study

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. [Ann Emerg Med. 1998]
Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
Carleton SC, Shesser RF, Pietrzak MP, Chudnofsky CR, Starkman S, Morris DL, Johnson G, Rhee KJ, Barton CW, Chelly JE, et al. Ann Emerg Med. 1998 Aug; 32(2):129-38.
Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. [Headache. 2001]
Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
Edwards KR, Norton J, Behnke M. Headache. 2001 Nov-Dec; 41(10):976-80.
[Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks]. [Pathol Biol (Paris). 1995]
[Calcium carbasalate-metoclopramide combination versus dihydroergotamine in the treatment of migraine attacks].
Pradalier A, Guérard des Lauriers A, Scheck F, Peraudeau P, Lacoste JP, Cajfinger F. Pathol Biol (Paris). 1995 Nov; 43(9):806-13.
Review Ergotamine tartrate and dihydroergotamine mesylate: safety profiles. [Headache. 1997]
Review Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
Lipton RB. Headache. 1997; 37 Suppl 1:S33-41.
Review Dosing and administration of ergotamine tartrate and dihydroergotamine. [Headache. 1997]
Review Dosing and administration of ergotamine tartrate and dihydroergotamine.
Mathew NT. Headache. 1997; 37 Suppl 1:S26-32.

See reviews... See all...

Cited by 1 PubMed Central article

Metoclopramide for acute migraine: a dose-finding randomized clinical trial. [Ann Emerg Med. 2011]
Metoclopramide for acute migraine: a dose-finding randomized clinical trial.
Friedman BW, Mulvey L, Esses D, Solorzano C, Paternoster J, Lipton RB, Gallagher EJ. Ann Emerg Med. 2011 May; 57(5):475-82.e1. Epub 2011 Jan 12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatme...
Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
Curr Pain Headache Rep. 2005 Feb ;9(1):65-70.

PubMed
Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallel...
Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
J Neuropathol Exp Neurol. 2004 Dec ;63(12):1236-42.

PubMed
Photodynamic therapy for the treatment of acne: a pilot study.
Photodynamic therapy for the treatment of acne: a pilot study.
J Drugs Dermatol. 2004 Nov-Dec ;3(6 Suppl):S10-4.

PubMed
Oxidative stress in autism.
Oxidative stress in autism.
Altern Ther Health Med. 2004 Nov-Dec ;10(6):22-36; quiz 37, 92.

PubMed
Effects of dietary supplements on space radiation-induced oxidative stress in Sp...
Effects of dietary supplements on space radiation-induced oxidative stress in Sprague-Dawley rats.
Radiat Res. 2004 Nov ;162(5):572-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: